Imagine you have an exam tomorrow and you’ve still got two long chapters left to study.
It’s 11pm and you’re falling asleep on your feet. A friend has told you about a pill that helps you stay up all night, wide awake and focused — perfect for studying.
What would you do?
In this post we’re going to try to analyze the effectiveness of “study drugs,” who uses them, and whether they actually work or are just a placebo — as always, based on rigorous research and data, not bar talk.
Introductions
Let’s introduce the best-known ones and their characteristics: caffeine, which supposedly keeps us sharp; amphetamines and methylphenidate, which supposedly help us memorize and stay focused (or so they say); and modafinil, marketed as not having the “high” of the others and being less addictive. But there are two more players in the game: energy drinks, and an old acquaintance we’ll get to later.
The most popular one
If we count consumption via energy drinks, caffeine is the most widely used stimulant for studying and performing at work, accounting for 23.5% and 41.4%, respectively, of consumption among students (Beyer/Lucke et al., BMC Public Health 2018 — Reliable). At the population level, 90% of adults regularly consume caffeine in some form.
It clearly works, right? Otherwise it wouldn’t be used so massively. Everyone who tries it notices the almost instant energy boost, though it varies from person to person. But here’s the thing: if I tell you that taking it makes your brain release dopamine and that it’s an addictive substance, you have to wonder — is it really waking me up, or is it just giving me the fix I need because I’m addicted to the substance? Let’s look at the data.
The DSM-5 — the Diagnostic and Statistical Manual of Mental Disorders — links abrupt cessation of caffeine intake with a withdrawal syndrome, which can cause headaches in about half of cases, along with anxiety and altered vital signs. Even so, the risk of serious clinical addiction is considered low compared to other substances.
The real problem with caffeine is the sleep cycle. Caffeine doesn’t actually wake you up — it blocks adenosine receptors, a molecule that makes us feel sleepy. And when the caffeine wears off (5–6 hours later), all the accumulated adenosine kicks in at once, making you even sleepier. If you keep drinking coffee, that adenosine “snowball” keeps growing, which means you don’t sleep well at night (even if it consciously feels like you did), and in the morning you need caffeine again just to feel normal.
But what really matters here is whether caffeine actually makes us perform better. In 2005, Rogers et al. ran two studies on the effects of caffeine on mental performance and mood. They split coffee drinkers into two groups: the first group abstained from caffeine for three weeks, while the second had no restrictions. Both groups were told to sleep only 5 hours that night and to avoid caffeine in the evening. Both groups were tested before and after taking caffeine or a placebo.
The result was surprising: those who had gone three weeks without caffeine showed virtually no difference in results before and after taking caffeine, despite the sleep deprivation — it simply had no effect on them. However, in those who regularly drank caffeine, performance clearly improved after taking it. The researchers concluded that caffeine doesn’t actually enhance mental performance — it simply reverses the withdrawal slump in habitual users.
In short: in situations of sleep deprivation, caffeine helps only slightly for people outside the “caffeine loop,” and quite a bit for those who are in it.
Methylphenidate, Modafinil, and Amphetamines
In 2023, Bowman, Coghill, Murawski & Bossaerts [4] ran a study on healthy adults across four separate sessions, one week apart, in which participants were given methylphenidate, modafinil, amphetamines, or a placebo. In each session they had to solve the “knapsack problem,” a time-constrained resource-optimization exercise that’s a good proxy for performance on complex daily tasks. The result was fairly unexpected: the placebo session produced the best results. Those who took methylphenidate also took 50% longer. The authors summarized it as the drugs increasing motivation and effort, but degrading the quality of reasoning. A serious issue they identified: students who normally performed in the top 25% frequently dropped to the bottom 25% under methylphenidate — not that it had no effect, but that it hurt performance while giving the student a false sense of having done better.
Franke et al. (2017) [6] tried to test whether chess performance could be pharmacologically enhanced. In this case, participants were separately given modafinil, methylphenidate, caffeine, or a placebo. All three compounds significantly increased thinking time, leading to more losses on time, but when time wasn’t a factor, performance was slightly better (4% for caffeine and methylphenidate, 2% for modafinil, versus placebo). Interestingly, the study’s headline coverage was that “smart drugs improve chess” — without accounting for the losses due to time.
There’s a very recent study on methylphenidate — Sambeth, Toth & Blokland (2025/2026) [5] — which is interesting because it was tested in real exams, not in a lab. Participants simply received one dose the day before studying and another before the exam, in placebo-placebo, placebo-MPH, or MPH-MPH combinations. The result: methylphenidate didn’t improve outcomes at all — all three groups had the same average grades and pass rates. In another 2015 study, Ilieva, Hook & Farah [7] found methylphenidate and amphetamines produced a slightly better result, but made clear the effects were small, if present at all.
However, other experiments with modafinil, such as Battleday & Brem (2015) [8], found more consistent improvements in attention and memory, albeit with some loss of creativity; they estimated an improvement in complex tasks without major side effects.
Repantis, Schlattmann, Laisney & Heuser, earlier in 2010 [9], had also experimented with modafinil and methylphenidate, and their analysis found some improvement from modafinil too, though lower than expected, standing out especially under sleep deprivation rather than boosting already well-rested subjects. The same study reported a slight memory improvement with methylphenidate in subjects.
Modafinil was also tested on surgeons under heavy workloads who could only sleep a few hours, putting their work efficiency at risk. Sugden et al. (2012) [10] gave surgeons either placebo or modafinil (I wouldn’t have wanted to be a patient those days) — the result was no improvement in surgical skill, but there was improvement on memory and planning tests. Still, it was a very small sample.
Energy drinks
Let’s go back to the player we set aside earlier. With energy drinks, it’s worth clearing up one thing right away: for studying, they don’t do anything that coffee’s caffeine doesn’t already do. What’s marketed as “energy” is, almost entirely, just caffeine; the taurine, guarana, or ginseng they usually include contribute little or nothing to mental performance — and guarana actually sneaks in even more caffeine, which throws off the dose. When you pay for an energy drink, you’re paying for caffeine plus sugar plus a handful of “cool”-looking additives.
As mentioned, the problem is that this caffeine arrives in a much less controlled dose. A cup of coffee has roughly 80–150 mg; an energy drink can range from 50 mg to over 500 mg per can — the equivalent of almost ten cans of Coca-Cola. Add to that the sugar: between 25 and 55 grams per serving in the sugared versions, with the spike and crash that come with it — exactly the opposite of what you need for an afternoon of studying.
In a 2022 crossover study, the same participants were given 240 mg of caffeine, once via coffee and once via an energy drink: the coffee didn’t affect a marker of cardiac electrical instability, while the energy drink did increase it. A pilot trial with the same dose found that the energy drink — but not the coffee — worsened systolic blood pressure and arterial stiffness. The reasonable takeaway isn’t “energy drinks will stop your heart,” but that at equal caffeine doses, the delivery vehicle matters: the additives and sugar seem to add a cardiovascular burden that coffee alone doesn’t. In fact, while emergency-room reports of arrhythmias and the occasional heart attack linked to energy drink abuse keep piling up, moderate coffee consumption shows the opposite effect in large population studies: it’s associated with lower mortality. Same star molecule, different outcome.
And here’s the irony for a post about studying. The largest review to date (Ajibo et al., 2024), which pooled 57 studies and more than 1.2 million children and adolescents across 21 countries, found a consistent association between energy drink consumption and worse sleep, more anxiety, worse concentration, and worse academic outcomes. Exactly the opposite of what’s on the can. It’s no coincidence that governments have started legislating: in Spain they’ve already been banned in schools since 2024, and in early 2026 the Ministry of Consumer Affairs announced its intention to ban sales to minors under 16 (and under 18 for higher-caffeine versions). The UK, Norway, and much of Eastern Europe are heading the same way. It’s hard to picture a “study booster” whose main recent claim to fame is that regulators want to ban it specifically for the group it’s supposedly helping most.
The old acquaintance
And now we get to the player I’d set aside earlier — not caffeine, but a much less innocent old acquaintance: cocaine. It sounds strange to bring it into a post about studying, but it’s in the data. In the ESTUDES survey, which Spain’s National Drug Plan runs among students aged 14 to 18, there’s a specific module on substances used “to improve study performance,” and among those who report using something, the most cited substance isn’t methylphenidate or modafinil — it’s cocaine, at around 24%.
Before alarm bells go off, the figure needs to be read carefully, because it’s misleading. It’s not that 24% of students snort coke to study; it’s that, within the small group (about 6–7% of the total) who admit to self-medicating to perform better, some mention cocaine. As a share of all students, we’re talking about something like 1.5%. And even that figure should be taken with a grain of salt: pharmacologically, cocaine is a terrible study aid (a half-hour effect, a brutal crash afterward, zero evidence it helps with memorization), and the survey itself lumps together “I used it to stay awake” and “I used it partying,” which in a teenager is a very blurry line. Translated: it probably reflects more of a polydrug-use profile than an actual “studying on coke” strategy. But the fact that the substance topping Spain’s official list of “study stimulants” is one with no evidence base for helping you study says a lot about how lost we are on this topic.
Conclusions
Once again, this piece makes clear that you have to be careful with what your friends tell you at the bar. These stimulants have become increasingly popular, but the studies show their effects are very mild or even counterproductive, in some cases creating a false sense of improved performance while actually lowering it.
Modafinil isn’t as “safe and effective” as it’s marketed to be — several studies show it can generate overconfidence, slow down response times, and reduce creativity. Methylphenidate also significantly slows down results and sometimes makes them worse.
On the other hand, for most of these compounds, the cases where they help most are when the subject is sleep-deprived, tired, or leading a sedentary life and not performing at their normal level. In other words, they help you get back to your normal level — they don’t enhance brain function beyond it.
What really matters for a healthy, efficient brain is having a proper foundation of health: sleeping and resting the hours you need (which helps with memory), exercising (which improves your mental state), and, of course, avoiding a sedentary lifestyle. And you know what? Those are free, and they come with no side effects.
REFERENCES
[1] Rogers PJ, Heatherley SV, Hayward RC, et al. Effects of caffeine and caffeine withdrawal on mood and cognitive performance degraded by sleep restriction. Psychopharmacology, 2005, 179(4):742–752. Reliable
[2] James JE, Rogers PJ. Effects of caffeine on performance and mood: withdrawal reversal is the most plausible explanation. Psychopharmacology / Australian Journal of Psychology, 2005. With reservations, hypothesis
[3] Sweeney, Griffiths et al. (2020). Caffeine addiction. Survey
[4] Bowman E, Coghill D, Murawski C, Bossaerts P. Not so smart? “Smart” drugs increase the level but decrease the quality of cognitive effort. Science Advances, 2023, 9(24):eadd4165. With reservations, recent
[5] Sambeth A, Toth M, Blokland A. Methylphenidate (Ritalin) does not improve exam performance in an experimental setting. Psychopharmacology, 2026, 243:593–600 (published online August 2025). With reservations, recent
[6] Franke AG, Gränsmark P, Agricola A, et al. Methylphenidate, modafinil, and caffeine for cognitive enhancement in chess: A double-blind, randomised controlled trial. European Neuropsychopharmacology, 2017, 27(3):248–260. Reliable
[7] Ilieva IP, Hook CJ, Farah MJ. Prescription Stimulants’ Effects on Healthy Inhibitory Control, Working Memory, and Episodic Memory: A Meta-analysis. Journal of Cognitive Neuroscience, 2015, 27(6):1069–1089. Reliable
[8] Battleday RM, Brem AK. Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review. European Neuropsychopharmacology, 2015, 25(11):1865–1881. Reliable
[9] Repantis D, Schlattmann P, Laisney O, Heuser I. Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review. Pharmacological Research, 2010, 62(3):187–206. Reliable
[10] Sugden C, Housden CR, Aggarwal R, Sahakian BJ, Darzi A. Effect of pharmacological enhancement on the cognitive and clinical psychomotor performance of sleep-deprived doctors: A randomized controlled trial. Annals of Surgery, 2012, 255(2):222–227. With reservations, primary source requires verification
[11] Ajibo C, et al. Energy drink consumption and health outcomes in children and young people: a systematic review. 2024. Reliable
[12] Impact of energy drink versus coffee consumption on periodic repolarization dynamics: an interventional study, 2022 (n=16). With reservations
[13] Comparable Analysis of Acute Changes in Vascular Tone after Coffee versus Energy Drink Consumption, 2022 (n=23). With reservations
[14] ESTUDES Survey 2023/2025, OEDA – Spanish National Drug Plan. Statistics
[15] Ministry of Consumer Affairs, announcement February 2026; Royal Decree on school cafeterias 2024. Institutional source